课题基金 / 基金详情

INTESTINAL SECRETORY MECHANISMS AND ANTIDIARRHEAL DRUGS

INTESTINAL SECRETORY MECHANISMS AND ANTIDIARRHEAL DRUGS
肠道分泌机制和止泻药
批准号:
3151877
负责人:
KIERTISIN DHARMSATHAPHORN
金额:
$15.67万
依托单位国家:
美国
项目类别:
财政年份:
1981
资助国家:
美国
项目状态:
已结题
起止时间:
1981-07-01 至 1989-03-31

项目摘要

项目成果

KIERTISIN DHARMSATHAPHORN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
A cultured epithelial cell line which retains specific electrolyte transport functions may serve as a model system to study those functions. Culture cells allow the transport processes to be studied in a homogeneous group of cells free of the confounding effect of other cell types. This is an advantaje which should allow better and more specific identification of the sequence of cellular events involved in a transport phenomenon, beginning with receptor binding to activation of intracellular amplifying mechanisms to stimulation of various transport pathways on the plasma membrane. Initial characterization of receptor-mediated ion transport properties in the T84 colonic cell line, an established human epithelial cell line, suggests that this cell line may serve as a useful secretory model system. In this proposal, the role of Cl- and K+ channels and Na+,K+,Cl- cotransport in cAMP and Ca++ mediated secretion will be further investigated in T84 cells. Initial studies suggest that these transport pathways are intimately involved in secretory mechanisms. Three methods will be used to study ion transport. 1) The Ussing chamber, to study transepithelial movement of ions. Synergism between cAMP and Ca++ mediated secretion will be tested, and the involvement of transport pathways and intracellular mediators in secretory processes will be studied. 2) Radionuclide uptake and efflux in whole cells to directly verify the specific transport pathways involved and to study their interactions. 3) Transport studies in purified brush border and basolateral membranes to localize transport pathways and determine its transport characteristics. The proposed studies should allow us to identify various transport pathways on the plasma membrane involved in the secretory events and provide information about the intracellular amplifying mechanisms. Information on the inhibition of transport pathways and the interruption of intracellular amplifying mechanisms should provide a rational approach to the development of antidiarrheal medications.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
Coordinate expression of piretanide receptors and Na+,K+,Cl- cotransport activity in Madin-Darby canine kidney cell mutants.
协调 Madin-Darby 犬肾细胞突变体中吡咯他尼受体的表达和 Na、K、Cl- 共转运活性。
DOI: --
发表时间: 1987
期刊: The Journal of biological chemistry
影响因子: --
作者: [Giesen-Crouse,EM, McRoberts,JA]
通讯作者: McRoberts,JA
Electrolyte transport in a human colonic cell line: regulation by cAMP and calcium.
人结肠细胞系中的电解质转运:cAMP 和钙的调节。
DOI: --
发表时间: 1984
期刊: Kroc Foundation series
影响因子: --
作者: [Cartwright,CA, McRoberts,JA, Mandel,KG, Masui,H, Dharmsathaphorn,K]
通讯作者: Dharmsathaphorn,K
Development of new antidiarrheal medications.
开发新的止泻药物。
DOI: 10.1097/00004836-198304000-00008
发表时间: 1983
期刊: Journal of clinical gastroenterology
影响因子: 2.9
作者: [Rosenthal,LE, Pressman,J, Dharmsathaphorn,K]
通讯作者: Dharmsathaphorn,K
T84 cell receptor binding and guanyl cyclase activation by Escherichia coli heat-stable toxin.
大肠杆菌热稳定毒素对 T84 细胞受体的结合和鸟苷酸环化酶的激活。
DOI: 10.1152/ajpgi.1987.253.6.g775
发表时间: 1987
期刊: The American journal of physiology
影响因子: --
作者: [Guarino,A, Cohen,M, Thompson,M, Dharmsathaphorn,K, Giannella,R]
通讯作者: Giannella,R
9
    DEVELOPMENT OF NEW ANTIDIARRHEAL AGENTS
    • 批准号:
      3072303
    • 项目类别:
    • 资助金额:
      $5.28万
    • 财政年份:
      1984
    • 负责人:
      KIERTISIN DHARMSATHAPHORN
    • 依托单位:
    DEVELOPMENT OF NEW ANTIDIARRHEAL AGENTS
    • 批准号:
      3072302
    • 项目类别:
    • 资助金额:
      $5.18万
    • 财政年份:
      1984
    • 负责人:
      KIERTISIN DHARMSATHAPHORN
    • 依托单位:
    DEVELOPMENT OF NEW ANTIDIARRHEAL AGENTS
    • 批准号:
      3072304
    • 项目类别:
    • 资助金额:
      $5.02万
    • 财政年份:
      1984
    • 负责人:
      KIERTISIN DHARMSATHAPHORN
    • 依托单位:
    DEVELOPMENT OF NEW ANTIDIARRHEAL AGENTS
    • 批准号:
      3071145
    • 项目类别:
    • 资助金额:
      $5.33万
    • 财政年份:
      1984
    • 负责人:
      KIERTISIN DHARMSATHAPHORN
    • 依托单位:
    海外基金